Brief Report: Association of Natural Killer Cell Ligand Polymorphism HLA–C Asn80Lys With the Development of Anti‐SSA/Ro–Associated Congenital Heart Block
Open Access
- 17 October 2017
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 69 (11) , 2170-2174
Abstract
Objective: Fetal exposure to maternal anti‐SSA/Ro antibodies is necessary but not sufficient for the development of autoimmune congenital heart block (CHB), suggesting that other factors, such as fetal genetic predisposition, are important. Given the previously described association between major histocompatibility complex alleles and CHB risk, we undertook the present study to test the hypothesis that a variant form of HLA–C Asn80Lys, which binds with high affinity to an inhibitory killer cell immunoglobulin‐like receptor (KIR) and thus renders natural killer (NK) cells incapable of restricting inflammation, contributes to the development of CHB.Methods: Members of 192 pedigrees in the US and Europe (194 cases of CHB, 91 unaffected siblings, 152 fathers, 167 mothers) and 1,073 out‐of‐study controls were genotyped on the Immunochip single‐nucleotide polymorphism microarray. Imputation was used to identify associations at HLA–C Asn80Lys (Asn, C1; Lys, C2) and KIR. Tests for association were performed using logistic regression. McNemar's test and the pedigree disequilibrium test (PDT) were used for matched analyses between affected and unaffected children.Results: Compared with out‐of‐study controls of the same sex, the C2 allele was less frequent in the mothers (odds ratio [OR] 0.63, P = 0.0014) and more frequent in the fathers (OR 1.40, P = 0.0123), yielding a significant sex‐by‐C2 interaction (P = 0.0002). The C2 allele was more frequent in affected siblings than in unaffected siblings (OR 3.67, P = 0.0025), which was consistent with the PDT results (P = 0.016); these results were observed in both sexes and across the US and European cohorts. There was no difference in the frequency of the inhibitory KIR genotype (KIR AA) between affected and unaffected children (P = 0.55).Conclusion: These data establish C2 as a novel genetic risk factor associated with CHB. This observation supports a model in which fetuses with C2 ligand expression and maternal anti‐SSA/Ro positivity may have impaired NK cell surveillance, resulting in unchecked cardiac inflammation and scarring.Keywords
Funding Information
- National Institutes of Health (R37-AR-042455)
- Alliance for Lupus Research
This publication has 15 references indexed in Scilit:
- Transancestral mapping and genetic load in systemic lupus erythematosusNature Communications, 2017
- KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapseBlood, 2014
- The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influenceJournal of Internal Medicine, 2014
- HIBAG—HLA genotype imputation with attribute baggingThe Pharmacogenomics Journal, 2013
- Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupusRheumatology, 2012
- The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomesProceedings of the National Academy of Sciences, 2010
- Identification of candidate loci at 6p21 and 21q22 in a genome‐wide association study of cardiac manifestations of neonatal lupusArthritis & Rheumatism, 2010
- Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLEEuropean Journal of Human Genetics, 2007
- Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responsesBlood, 2006
- A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypesThe Journal of Immunology, 1997